Fluoroquinolone use and Clostridium difficile-associated diarrhea

Emerg Infect Dis. 2003 Jun;9(6):730-3. doi: 10.3201/eid0906.020385.

Abstract

We performed a case-control study to evaluate the association between antibiotic use and Clostridium difficile-associated diarrhea (CDAD), matching for admission unit and time at risk for CDAD. A multivariable regression model showed that treatment with fluoroquinolones (odds ratio 12.7; 95% confidence interval 2.6 to 61.6) was the strongest risk factor for CDAD.

MeSH terms

  • Aged
  • Case-Control Studies
  • Clostridioides difficile* / isolation & purification
  • Clostridium Infections / diagnosis
  • Clostridium Infections / epidemiology
  • Clostridium Infections / etiology*
  • Cross Infection / epidemiology
  • Diarrhea / diagnosis
  • Diarrhea / epidemiology
  • Diarrhea / etiology
  • Diarrhea / microbiology*
  • Female
  • Fluoroquinolones / adverse effects*
  • Fluoroquinolones / pharmacology
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Risk Factors

Substances

  • Fluoroquinolones